NCT01075594|Completed
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
CEPHEUS
Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia
Loading search results
CEPHEUS
Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia
Sponsor study identifier
observational
2,500
1 country
15
Study Start
February 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2010
Actual (reported)Study Completion
August 2010
Actual (reported)The purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2010
Date type not reportedThis date has not been verified as actual or estimated.
February 19, 2010
Actual (reported)February 25, 2010
Actual (reported)August 2010
Actual (reported)August 2010
Actual (reported)The number and percentage of patients achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines
6 months - one visit only, no follow-up visits
The number and percentage of subjects achieving the LDL-C goals, according to the Fourth Joint European Task Force guidelines for several subject subsets
6 months - one visit only, no follow-up visits
The number and percentage of subjects achieving LDL-C goals according to the NCEP ATP III / 2004 updated 2004 NCEP ATP III guidelines, overall and for several subject subsets
6 months - one visit only, no follow-up visits
The number and percentage of subjects achieving the non HDL-C goals according to the NCEP ATP III/updated 2004 NCEP ATP III/national guidelines [<130mg/dL (3,37mmol/L)], in the following sub-population: patients with fasting triglycerides >200 mg/dL
6 months - one visit only, no follow-up visits
Patients with dyslipidemia on lipid lowering therapy
Primary care clinic
Research Site
Blagoevgrad, Bulgaria
Research Site
Burgas, Bulgaria
Research Site
Haskovo, Bulgaria
Research Site
Montana, Bulgaria
Research Site
Pazardzhik, Bulgaria
Research Site
Pleven, Bulgaria
Research Site
Plovdiv, Bulgaria
Research Site
whole blood, serum
2,500 participants (actual enrollment reported by the registry).
First Submitted
February 19, 2010
First Posted
February 25, 2010
Study Start
February 2010
Date type not reportedThis date has not been verified as actual or estimated.
Observational Study To Evaluate Statins Patterns Of Use In Spain
Contact the study team to confirm eligibility.
Rousse, Bulgaria
Research Site
Shumen, Bulgaria
Research Site
Sliven, Bulgaria
Research Site
Smolyan, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Stara Zagora, Bulgaria
Research Site
Varna, Bulgaria
Research Site
Veliko Tarnovo, Bulgaria
Primary Completion
August 2010
Actual (reported)Study Completion
August 2010
Actual (reported)Last Updated
September 10, 2010
Record last verified: 2010-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: